Stock NTLA INTELLIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Real-time Estimate Cboe BZX
Other stock markets
 03:01:45 2024-04-29 pm EDT 		5-day change 1st Jan Change
21.9 USD +5.49% Intraday chart for Intellia Therapeutics, Inc. +1.19% -27.55%
Apr. 15 Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer CI
Mar. 25 Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. NTLA Stock
  4. Revisions Intellia Therapeutics, Inc.